The expression of Cdk inhibitors p27kip1 and p57kip2 in mouse placenta and human choriocarcinoma JEG-3 cells

Placenta

Volumn 26, Issue 1, 2005, Pages 73-80

  Kim, S T ^a   Lee, S K ^a   Gye, M C ^b  

^a Konyang University College of Medicine   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 1C; DEXAMETHASONE; ESTRADIOL; MESSENGER RNA; STEROID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARCINOMA CELL; CHORIOCARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; DECIDUA; DEVELOPMENTAL STAGE; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TROPHOBLAST; TUMOR CELL CULTURE; TUMOR CELL LINE; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CHORIOCARCINOMA; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASE INHIBITOR P57; DEXAMETHASONE; DNA PRIMERS; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED ICR; NUCLEAR PROTEINS; PLACENTA; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 12344258595     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2004.04.008     Document Type: Article

References (20)

1. Cross J.C. Werb Z. Fisher S.J. Implantation and the placenta: key pieces of the development puzzle Science 266 1994 1508-1518
2. Benirschke K. In: Bernischke K. Kaufmann P. Editors. Choriocarcinoma in pathology of the human placenta 3rd ed. 1995 686-708 Springer New York
3. Lew D.J. Dulic V. Reed S.I. Isolation of the three novel human cyclins by rescue of cyclin (Cln) function in yeast cell Cell 66 1991 1197-1206
4. Sherr C.J. G phase progression: Cycling on cue Cell 79 1991 551-555
5. Sherr C.J. Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases Genes Dev 9 1995 1149-1163
6. Zavitz K.H. Zipursky S.L. Controlling cell proliferation in differentiating tissue: Genetic analysis of negative regulators of G1 → S-phase progression Curr Opin Cell Biol 9 1997 773-781
7. Hirama T. Koeffler H.P. Role of cyclin-dependent kinase inhibitors in the development of cancer Blood 86 1995 841-854
8. cip1 Cdk inhibitor family, is a candidate tumor suppressor gene Genes Dev 9 1995 650-662
9. Loda M. Cukor B. Tam S.W. Lavin P. Fiorentino M. Draetta G.F. et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas Nat Med 3 1997 231-234
10. KIP2 in the control of tissue growth and development Genes Dev 12 1998 3162-3167
11. Kip2 regulates the proper development of labyrinthine and spongiotrophoblasts Mol Hum Reprod 6 2000 1019-1025
12. Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution Genes Dev 9 1995 639-649
13. KIP2, on chromosome 11p15 Proc Natl Acad Sci U S A 93 1996 3026-3030
14. KIP2 indicates a role in Beckwith-Wiedemann syndrome Nature 387 1997 151-158
15. Kip2 results in increased apoptosis and delayed differentiation during mouse development Genes Dev 11 1997 973-983
16. Kip2, exhibit skeletal abnormalities and growth retardation J Biochem 127 2000 73-83
17. kip2, a maternally imprinted Cdk inhibitor, in normal human placenta and gestational trophoblastic disease Lab Invest 78 1998 269-276
18. kip2 expression induces preeclampsia-like symptoms in mice Mol Hum Reprod 8 2002 1129-1135
19. Kip1-deficient mice Cell 85 1996 733-744
20. Kip1 in growth inhibition of endometrium in the secretory phase and of hyperplastic endometrium treated with progesterone Mol Hum Reprod 4 1998 899-905